FDA Orphan Drug Designation for a New Neuroendocrine Tumor Treatment!
source: pixabay.com

FDA Orphan Drug Designation for a New Neuroendocrine Tumor Treatment!

Neuroendocrine tumors are growths which form from neuroendocrine cells in various places throughout the body. They can occur in the gastrointestinal track, the pancreas, the lungs, the thymus, and other…

Continue Reading FDA Orphan Drug Designation for a New Neuroendocrine Tumor Treatment!
This Jewish Australian Teenager With Gaucher Disease Just Launched a Support Group for Patients
source: pixabay.com

This Jewish Australian Teenager With Gaucher Disease Just Launched a Support Group for Patients

According to a story from the Australian Jewish News, a Jewish teen named Gidon Goodman was born with Gaucher disease. Recently, he started the first Gaucher disease patient support group…

Continue Reading This Jewish Australian Teenager With Gaucher Disease Just Launched a Support Group for Patients
Data From a Phase 2 Nonalcoholic Fatty Liver Disease Trial Looks Promising
luvqs / Pixabay

Data From a Phase 2 Nonalcoholic Fatty Liver Disease Trial Looks Promising

According to a story from tradeshownews.vporoom.com, the biopharmaceutical company Viking Therapeutics, Inc., has recently released the results from a Phase 2 clinical trial. This trial is testing the company's investigational therapeutic…

Continue Reading Data From a Phase 2 Nonalcoholic Fatty Liver Disease Trial Looks Promising
Participants in a Duchenne Muscular Dystrophy Clinical Trial Found out the Drug Wasn’t Working on Social Media
source: pixabay.com

Participants in a Duchenne Muscular Dystrophy Clinical Trial Found out the Drug Wasn’t Working on Social Media

According to a story from nature.com, Amber Sapp's twelve year old son Garrett had been participating in a clinical trial that was testing a new potential treatment for his Duchenne…

Continue Reading Participants in a Duchenne Muscular Dystrophy Clinical Trial Found out the Drug Wasn’t Working on Social Media